Vidcast:  https://youtu.be/AeWBdbS5mgY

 

The quantitative measurement of cell-free DNA methylation patterns, the so-called Gallieri test, offer real promise as a screen for cancers that currently popup unannounced and kills way too many of us.  These include cancers in the liver, small intestine, uterus, pancreas, bone, bile ducts, lung, ovary, as well as lymphomas and plasma cell myelomas.  

 

The test was evaluated in over 6600 persons and it detected 99.5% of all cancers.  The bad news is that this diagnostic procedure currently has a 30% false positive rate.  It blows the whistle too often and leads to many unnecessary biopsies and tests. Nonetheless, further refinement of the process should improve the test specificity and allow the detection of many now deadly cancers at earlier stages when medical and surgical therapy can effectively eradicate them.

 

https://www.medicalnewstoday.com/articles/gallieri-blood-test-may-detect-cancers-that-are-hard-to-diagnose#Pros-and-cons-of-the-test

 

#gallieri #dnamethylation #cancer #pancrea #liver #ovary #uterus